The FDA approval sprang from a groundbreaking trial of 107 patients in South Africa who had been diagnosed with XDR-TB. Six months after treatment, 89% of the patients were cured, which is far higher than typical success rates for treatment of this often lethal strain of TB
from WebMD Health https://www.webmd.com/lung/news/20190815/fda-approves-drug-for-most-deadly-form-of-tb?src=RSS_PUBLIC
0 Comments:
Post a Comment